SRR1472663
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1488651 | GTEX | — | 0.969 |
| 2 | SRR1451964 | GTEX | — | 0.965 |
| 3 | SRR1479759 | GTEX | — | 0.961 |
| 4 | SRR1330675 | GTEX | — | 0.960 |
| 5 | BS_EXYHZ6D4 | pilocytic astrocytoma | — | 0.959 |
| 6 | SRR1474886 | GTEX | — | 0.958 |
| 7 | SRR1446287 | GTEX | — | 0.957 |
| 8 | SRR1340301 | GTEX | — | 0.955 |
| 9 | SRR1336006 | GTEX | — | 0.954 |
| 10 | SRR662091 | GTEX | — | 0.953 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 15 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.484 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.317 | Cobimetinib | — uncovered |
| MYOGENESIS | 0.266 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.235 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.226 | Inavolisib | — uncovered |
| COAGULATION | 0.223 | Binimetinib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.160 | Idelalisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.127 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.104 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.076 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.071 | Idelalisib | — uncovered |
| APICAL_SURFACE | 0.069 | Temsirolimus | — uncovered |
| HEDGEHOG_SIGNALING | 0.058 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.010 | Idelalisib | — uncovered |
| KRAS_SIGNALING_UP | 0.007 | Inavolisib | — uncovered |